CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Renata Medical Closes $25M Series D Financing Led by Global Healthcare Investment Firm ARCHIMED to Accelerate Commercialization and Development of Pediatric Cardiovascular Technologies

Positive
AI Analysis

Summary

Renata Medical, a privately held medical technology company focused on pediatric cardiovascular care, closed a $25 million Series D financing round led by ARCHIMED to accelerate commercialization and development of its congenital heart disease technologies.

Importance:5/10
Sentiment:
0.60
Series D financingpediatric cardiovascularcongenital heart diseasemedical devicescommercialization
Related Companies

Read the original article

Published by PR Newswire Biotech on August 19, 2026 12:30 PM

Read Original